Long-Term Therapeutic Outcomes of Photodynamic Therapy-Based or Photocoagulation-Based Treatments on Retinal Capillary Hemangioma
- 1 January 2018
- journal article
- research article
- Published by SAGE Publications in Photomedicine and Laser Surgery
- Vol. 36 (1) , 10-17
Abstract
Background: Retinal capillary hemangioma (RCH) is a rare and refractory eye tumor. Objective: The aim of this study was to investigate the therapeutic efficacy of two laser-based therapies for RCH, photodynamic therapy (PDT), and focal photocoagulation-based treatment. Materials and methods: This was a retrospective study. Eight RCH patients (10 eyes) receiving laser treatment and followed up from November 2011 to December 2016 in our hospital were selected and their medical records reviewed. Clinical results and correlations between various clinicodemographic factors and vision outcome were analyzed. Results: A total of 39 RCH tumor bodies were found and treated. Eleven sessions of PDT and 25 sessions of photocoagulation were administered. Other treatments included five intravitreal injections of antivascular endothelial growth factor or triamcinolone acetonide and one vitreoretinal surgery. After the follow-up period of 54.3 ± 29.8 months, 35 tumor bodies were stable or regressed, and 4 were recurrent. Vision was improved in four eyes, stable in one, and reduced in five relative to baseline. Photocoagulation was more likely to induce tumor bleeding than PDT (4 eyes vs. 1) and to increase subretinal fluid (3 eyes vs. 1). In correlation analysis, subretinal fluid accumulation was predictive of poor vision outcome ( r = 0.69, p = 0.03). Conclusions: Photodynamic- and photocoagulation-based therapies are both reasonably effective against most RCH tumor bodies, but PDT carries lower risks of bleeding and subretinal fluid refraction. Formation of subretinal fluid may predict poor vision outcome in RCH.Keywords
This publication has 18 references indexed in Scilit:
- Verteporfin photodynamic therapy for the treatment of sporadic retinal capillary haemangioblastomaPhotodiagnosis and Photodynamic Therapy, 2015
- THERAPEUTIC OUTCOMES OF RETINAL HEMANGIOBLASTOMASRetina, 2014
- Persistent exudative retinal detachment after photodynamic therapy and intravitreal bevacizumab injection for multiple retinal capillary hemangiomas in a patient with von Hippel–Lindau diseaseJournal of the Chinese Medical Association, 2014
- A Large Retinal Capillary Hemangioma in the Anterior Retina Treated with Photodynamic TherapyCase Reports in Ophthalmology, 2012
- Vitreoretinal Surgery for Severe Retinal Capillary Hemangiomas in Von Hippel–Lindau DiseaseOphthalmology, 2011
- Retinal Hemangioblastoma in von Hippel–Lindau DiseaseNew England Journal of Medicine, 2010
- Spontaneous Regression of a Retinal Capillary HemangiomaRetina, 2008
- INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY WITH PEGAPTANIB FOR ADVANCED VON HIPPEL-LINDAU DISEASE OF THE RETINARetina, 2007
- Juxtapapillary hemangioma: a case report and review of clinical features and management of von Hippel-Lindau diseaseOptometry - Journal of the American Optometric Association, 2005
- Treatment of retinal capillary hemangiomaOphthalmology, 2002